Insmed reported $31.08M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acelrx Pharmaceuticals ACRX:US $ 1.94M 1.29M
Alexion Pharmaceuticals ALXN:US $ 125.3M 6.7M
Alimera Sciences ALIM:US $ 7.08M 0.74M
Arena Pharmaceuticals ARNA:US $ 3.78M 5.76M
Cytokinetics CYTK:US $ 14.93M 7.16M
Dynavax Technologies DVAX:US $ 12.08M 8.93M
Flexion Therapeutics FLXN:US $ 5.47M 1.18M
Heron Therapeutics HRTX:US $ 11.24M 9.55M
Insmed INSM:US $ 31.08M 8.66M
Mirati Therapeutics MRTX:US $ 23.87M 4.27M
Novartis NVS:US $ 4811M 229M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Sarepta Therapeutics SRPT:US $ 76.68M 0.03M
Seattle Genetics SGEN:US $ 102.4M 5.64M
Ultragenyx Pharmaceutical RARE:US $ 21.79M 6.05M
Vertex Pharmaceuticals VRTX:US $ 127.53M 0.3M